AN2 Therapeutics Inc.

NASDAQ: ANTX · Real-Time Price · USD
1.13
0.06 (5.61%)
At close: Aug 18, 2025, 3:59 PM
1.14
1.33%
After-hours: Aug 18, 2025, 06:43 PM EDT

AN2 Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-51.32M -64.73M -40.96M -21.54M
Depreciation & Amortization
n/a n/a -692K n/a
Stock-Based Compensation
8.34M 8.41M 4.39M 974K
Other Working Capital
-3.64M 5.28M 1.22M -385K
Other Non-Cash Items
-3.28M -2.8M 77K 53K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-3M 5.83M 3.72M 32K
Operating Cash Flow
-49.26M -53.29M -33.46M -20.48M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-46.75M -132.18M -93.84M -77.27M
Sales Maturities Of Investments
101.34M 88.9M 72.06M 27.25M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
54.59M -43.28M -21.77M -50.02M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -11K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 465K -11K -1.2M
Financial Cash Flow
372K 84.99M 70.36M 78.53M
Net Cash Flow
5.7M -11.57M 15.12M 8.03M
Free Cash Flow
-49.26M -53.29M -33.46M -20.48M